DE602006019206D1 - Verfahren zur diagnose von multipler sklerose - Google Patents

Verfahren zur diagnose von multipler sklerose

Info

Publication number
DE602006019206D1
DE602006019206D1 DE602006019206T DE602006019206T DE602006019206D1 DE 602006019206 D1 DE602006019206 D1 DE 602006019206D1 DE 602006019206 T DE602006019206 T DE 602006019206T DE 602006019206 T DE602006019206 T DE 602006019206T DE 602006019206 D1 DE602006019206 D1 DE 602006019206D1
Authority
DE
Germany
Prior art keywords
multiple sclerosis
diagnosis
reagent
application
glycan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006019206T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Mikael Scwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycominds Ltd
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Publication of DE602006019206D1 publication Critical patent/DE602006019206D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
DE602006019206T 2005-01-31 2006-01-31 Verfahren zur diagnose von multipler sklerose Active DE602006019206D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/047,124 US7572592B2 (en) 2005-01-31 2005-01-31 Method for diagnosing multiple sclerosis
PCT/IB2006/001656 WO2006117689A2 (en) 2005-01-31 2006-01-31 Method for diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
DE602006019206D1 true DE602006019206D1 (de) 2011-02-10

Family

ID=36757039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006019206T Active DE602006019206D1 (de) 2005-01-31 2006-01-31 Verfahren zur diagnose von multipler sklerose

Country Status (15)

Country Link
US (4) US7572592B2 (de)
EP (1) EP1856531B1 (de)
AT (1) ATE493656T1 (de)
AU (1) AU2006242939B2 (de)
CA (1) CA2595277A1 (de)
CY (1) CY1111839T1 (de)
DE (1) DE602006019206D1 (de)
DK (1) DK1856531T3 (de)
ES (1) ES2358606T3 (de)
IL (1) IL184905A (de)
NZ (1) NZ560978A (de)
PL (1) PL1856531T3 (de)
PT (1) PT1856531E (de)
SI (1) SI1856531T1 (de)
WO (1) WO2006117689A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05001270A (es) * 2002-08-02 2005-08-03 Glycominds Ltd Metodo para diagnostico de esclerosis multiple.
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US20100105085A1 (en) * 2006-08-29 2010-04-29 Nir Dotan Method of diagnosing and stratifying anti-phospholipid syndrome
AU2009205956B2 (en) 2008-01-18 2015-07-02 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
AU2009315230A1 (en) 2008-11-12 2010-05-20 The Brigham And Women's Hospital, Inc. Diagnosis of multiple sclerosis
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
WO2011031472A2 (en) * 2009-08-25 2011-03-17 The Johns Hopkins University Detection of auto-antibodies to specific glycans as diagnostic tests for autoimmune diseases
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
EP2596116A4 (de) 2010-07-23 2014-03-19 Harvard College Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
CN103124795A (zh) 2010-07-23 2013-05-29 哈佛大学校长及研究员协会 利用吞噬细胞检测疾病或病症的方法
US20120053073A1 (en) 2010-07-23 2012-03-01 President And Fellows Of Harvard College Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
US20150275298A1 (en) 2012-06-15 2015-10-01 Harry Stylli Methods of detecting diseases or conditions
WO2013188828A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2015089443A2 (en) * 2013-12-12 2015-06-18 The Brigham And Women's Hospital, Inc. Treating neurodegenerative disease
EP3693742B1 (de) 2014-09-11 2022-04-06 Harry Stylli Verfahren zum nachweis von prostatakrebs
WO2016123565A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of ms disease course
US10538794B2 (en) 2016-11-29 2020-01-21 Emory University Oligosaccharide libraries and methods of production
EP3401682A1 (de) * 2017-05-09 2018-11-14 Université de Nantes Diagnose, vorbeugung und behandlung von demyelinisierenden erkrankungen des zentralen nervensystems
WO2021158839A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158841A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158843A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158847A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158844A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158845A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
US11135197B2 (en) 2020-02-07 2021-10-05 Argentum Pharmaceuticals Llc Dosage regimen of an S1P receptor modulator

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030560A (en) 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
CA2365250A1 (en) 1999-02-17 2000-08-24 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
AU2786801A (en) 2000-01-10 2001-07-24 Genospectra, Inc. Linear probe carrier
US20020098513A1 (en) 2000-02-17 2002-07-25 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
WO2002018950A1 (en) 2000-08-28 2002-03-07 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
MXPA05001270A (es) * 2002-08-02 2005-08-03 Glycominds Ltd Metodo para diagnostico de esclerosis multiple.
WO2004034031A2 (en) 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
US20060234301A1 (en) 2006-10-19
EP1856531B1 (de) 2010-12-29
NZ560978A (en) 2010-12-24
AU2006242939A1 (en) 2006-11-09
AU2006242939B2 (en) 2012-04-19
PT1856531E (pt) 2011-03-24
DK1856531T3 (da) 2011-04-18
US7906291B2 (en) 2011-03-15
CY1111839T1 (el) 2015-10-07
CA2595277A1 (en) 2006-11-09
SI1856531T1 (sl) 2011-05-31
EP1856531A2 (de) 2007-11-21
WO2006117689A3 (en) 2007-01-25
US20090291456A1 (en) 2009-11-26
ATE493656T1 (de) 2011-01-15
PL1856531T3 (pl) 2011-07-29
US7572592B2 (en) 2009-08-11
US8129128B2 (en) 2012-03-06
WO2006117689A2 (en) 2006-11-09
ES2358606T3 (es) 2011-05-12
US20110092383A1 (en) 2011-04-21
US20060172338A1 (en) 2006-08-03
IL184905A (en) 2012-02-29
IL184905A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
DE602006019206D1 (de) Verfahren zur diagnose von multipler sklerose
ATE479100T1 (de) Verfahren zur diagnose von lawsonia intracellularis
ATE507720T1 (de) Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
DE60326567D1 (de) Diagnose von hepatozellulärem karzinom
DE602007002061D1 (de) Verfahren zur echtzeitschätzung von motorverbrennungsparametern aus schwingungssignalen
NZ704383A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE602007011856D1 (de) Verfahren zur Gewinnung von Bildern aus Probenscheiben
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
RS54879B1 (sr) Metode i kompozicije za dijagnoze i prognoze oštećenja bubrega i bubrežne insuficijencije
ATE524561T1 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
WO2008037806A3 (en) Method for determining the allergic potential of a compound
TR201900481T4 (tr) Bağışıklık testi için aparat ve kit.
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
DE602005016420D1 (de) Verfahren und kits zur messung von adamts13/fxi-komplexen
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
ATE518139T1 (de) Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers
EA201290106A1 (ru) Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE485060T1 (de) Verfahren zur diagnose von infektionskrankheiten
DE60333195D1 (de) Verfahren zur diagnose des myokardinfarktrisikos
ATE460656T1 (de) Verfahren zur absicherung der zuverlässigkeit von technischen bauteilen
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression